A narrative review published in Biology (MDPI, analyzing data from 78 studies) examined the mechanistic basis of GLP-1 receptor agonist-related oral adverse effects
This remarkable compound triggers healing through multiple biological pathways simultaneously, including increased blood vessel formation, enhanced cell migration to injury sites, and amplified growth hormone receptor activity
If you stop GLP-1 medications completely, your sugar levels, appetite, and weight may return to pre-treatment levels
Patients should be monitored by their prescribing clinician, especially those taking cardiac medications
A prespecified nephrology analysis showed a 22% relative risk reduction in the composite renal endpoint (new macro-albuminuria, doubling of serum creatinine, dialysis, or renal death) driven mainly by a 26% fall in new-onset macro-albuminuria [8, 36]
There is a strong correlation between gaining weight and the risk of developing obstructive sleep apnea, explained Ren-Fielding, due to fat deposits in the neck and tongue